Idun Biologics ApS: Financial statements 2024
CVR: 43750380
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Idun Biologics ApS (CVR 43750380) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 516,626 and a net result of DKK -192,043 compared with DKK -2,287 the year before. That is a decrease of 22% compared with the year before. Equity in the 2024 report amounted to DKK -154,330. The company had 2 employees in the financial year.
- Gross Profit
- DKK 516,626
- Profit/Loss
- DKK -192,043
- Equity
- DKK -154,330
- Total Assets
- DKK 833,559
- Employees
- 2
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Idun Biologics ApS has published its annual report for 2023. Gross profit came to DKK 662,220, and the net result was DKK -2,287.
About Idun Biologics ApS
Idun Biologics ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Clarisse Eve Chiche-Lapierre and Jens Frederik Teilfeldt Hansen. The company is owned by Ymir Holdings ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 475,329 and a net result of DKK -85,011 compared with DKK -192,043 the year before. Equity in the 2025 report amounted to DKK -239,341.
